Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytomed Therapeutics Limited (GDTC)

Cytomed Therapeutics Limited (GDTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,815
  • Shares Outstanding, K 10,940
  • Annual Sales, $ 50 K
  • Annual Income, $ -1,840 K
  • EBIT $ 0 M
  • EBITDA $ -1 M
  • 60-Month Beta -0.14
  • Price/Sales 69.54
  • Price/Cash Flow N/A
  • Price/Book 1.78

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7800 +38.46%
on 01/30/26
1.2500 -13.60%
on 02/05/26
+0.2443 (+29.23%)
since 01/27/26
3-Month
0.7282 +48.31%
on 01/27/26
2.1200 -49.06%
on 12/08/25
-0.8207 (-43.18%)
since 11/26/25
52-Week
0.7282 +48.31%
on 01/27/26
3.6800 -70.65%
on 10/22/25
-1.7200 (-61.43%)
since 02/27/25

Most Recent Stories

More News
CytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

GDTC : 1.0800 (unch)
CytoMed Therapeutics Unveils Promising AML Therapy Research

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. CytoMed Therapeutics...

GDTC : 1.0800 (unch)
Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration

The global population is rapidly aging. According to the World Population Prospects 2022 published by the United Nations, there were

GDTC : 1.0800 (unch)
Singapore’s Journey to Becoming a Biotech Powerhouse

Singapore's Biotech Vision: From 2000 Onwards In 2000, Singapore embarked on an ambitious mission to establish itself as a leading

GDTC : 1.0800 (unch)
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...

GDTC : 1.0800 (unch)
Singapore’s Leap into the Future of Cell and Gene Therapies

Singapore is making remarkable progress in the realm of cell and gene therapy (CGT), as evidenced by the inauguration of

GDTC : 1.0800 (unch)
CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Singapore, Singapore--(Newsfile Corp. - August 17, 2023) - CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company") announced today it will be presenting at the August 24th, 2023 virtual Investor...

GDTC : 1.0800 (unch)
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency

/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...

GDTC : 1.0800 (unch)
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

/PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its...

GDTC : 1.0800 (unch)
The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology

CytoMed Therapeutics, a NASDAQ-listed company (Stock Symbol: GDTC), is at the forefront of a revolution in cellular therapy for cancers.

GDTC : 1.0800 (unch)

Business Summary

CytoMed Therapeutics Limited is a pre-clinical biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. CytoMed Therapeutics Limited is based in SINGAPORE.

See More

Key Turning Points

3rd Resistance Point 1.1867
2nd Resistance Point 1.1333
1st Resistance Point 1.1067
Last Price 1.0800
1st Support Level 1.0267
2nd Support Level 0.9733
3rd Support Level 0.9467

See More

52-Week High 3.6800
Fibonacci 61.8% 2.5524
Fibonacci 50% 2.2041
Fibonacci 38.2% 1.8558
Last Price 1.0800
52-Week Low 0.7282

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar